SAENGER BRADLEY
Insider CIK 1668150 · TNXP Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TNXP Tonix Pharmaceuticals Hold | J Other | 2026-06-30 | 2026-07-09 | 1,453 | $10.91 | $15.9K | 2,154 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2026-02-24 | 2026-02-26 | 39,011 | — | $0 | 39,011 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2026-02-24 | 2026-02-26 | 39,012 | — | $0 | 39,012 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2025-02-25 | 2025-02-27 | 25,792 | — | $0 | 25,792 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2025-02-25 | 2025-02-27 | 25,792 | — | $0 | 25,792 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | J Other | 2025-02-05 | 2025-02-27 | 0 | — | $0 | 0 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2024-02-27 | 2024-02-29 | 282,000 | — | $0 | 282,000 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2024-02-27 | 2024-02-29 | 282,000 | — | $0 | 282,000 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2023-02-23 | 2023-02-24 | 200,000 | — | $0 | 200,000 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2023-02-23 | 2023-02-24 | 200,000 | — | $0 | 200,000 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2022-02-15 | 2022-02-17 | 900,000 | — | $0 | 900,000 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2022-02-15 | 2022-02-17 | 900,000 | — | $0 | 900,000 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2022-02-15 | 2022-02-17 | 900,000 | — | $0 | 900,000 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2022-02-15 | 2022-02-17 | 900,000 | — | $0 | 900,000 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2021-02-23 | 2021-02-25 | 540,000 | — | $0 | 540,000 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2021-02-23 | 2021-02-25 | 540,000 | — | $0 | 540,000 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2020-05-04 | 2020-05-06 | 360,000 | — | $0 | 360,000 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2020-05-04 | 2020-05-06 | 360,000 | — | $0 | 360,000 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2020-02-25 | 2020-02-27 | 24,000 | — | $0 | 24,000 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2020-02-25 | 2020-02-27 | 24,000 | — | $0 | 24,000 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2019-05-06 | 2019-05-08 | 28,835 | — | $0 | 28,835 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2019-05-06 | 2019-05-08 | 28,835 | — | $0 | 28,835 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2019-02-26 | 2019-02-27 | 5,170 | — | $0 | 5,170 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2019-02-26 | 2019-02-27 | 5,170 | — | $0 | 5,170 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | P Buy | 2018-06-14 | 2018-06-14 | 300 | $4.10 | $1.2K | 3,079 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2018-02-13 | 2018-02-15 | 39,150 | — | $0 | 39,150 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2018-02-13 | 2018-02-15 | 39,150 | — | $0 | 39,150 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2017-03-01 | 2017-03-01 | 47,500 | — | $0 | 47,500 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2017-03-01 | 2017-03-01 | 47,500 | — | $0 | 47,500 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | P Buy | 2016-06-21 | 2016-06-21 | 2,000 | $2.00 | $4.0K | 6,039 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2016-05-27 | 2016-05-31 | 60,000 | — | $0 | 60,000 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2016-05-27 | 2016-05-31 | 20,000 | — | $0 | 20,000 | SEC↗ |